It’s been a great week for this FTSE 250 legend. But will it last?
The share price of Dr Martens (LSE:DOCS), the renowned FTSE 250 bootmaker, has risen 17.9% over the past four trading days. The catalyst appears to be a note from Peel Hunt stating that the group is âmaking headwayâ.
The broker claims the investment case looks âincreasingly positiveâ. It has set a new price target of 112p, which is around 27% higher than today’s (21 August) closing value. However, both remain well below the 370p offer price when the group listed in January 2021.
A difficult period
Since floating, the company’s struggled with falling demand. In light of its difficulties, it implemented a new strategy with an emphasis on cutting out wholesalers and diversifying into other product lines.
Comparing the groupâs results for the year ended 31 March (FY25) with those two earlier years reveals a 21.5% drop in revenue and an 80% fall in adjusted profit before tax (PBT).
But thereâs one financial measure thatâs going in the other direction. Its gross profit margin improved from 61.8% in FY23 to 65% in FY25. In FY20 — the last full year before its IPO — it was 59.7%.
| Measure | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue (£m) | 1,003.3 | 877.1 | 787.6 |
| Adjusted profit before tax (£m) | 174.0 | 97.2 | 34.1 |
| Gross margin (%) | 61.8 | 65.6 | 65.0 |
On its website, the iconic 1460 boot — which still accounts for around 40% of sales — retails for £170. All other things being equal, a margin improvement of 5.3 percentage points means an additional £9 profit a pair. But a fall in sales means this hasnât translated into a better bottom line. The group sold 0.6m fewer pairs of boots and sandals in FY25 than it did in FY20.
| Year | Pairs sold (m) |
|---|---|
| FY20 | 11.1 |
| FY21 | 12.7 |
| FY22 | 14.1 |
| FY23 | 13.8 |
| FY24 | 11.5 |
| FY25 | 10.5 |
Mixed messages
And I think the groupâs margin is an important issue to consider.
Its advertising targets a young, cool and trendy demographic yet its 65% margin is typical of a luxury brand. For example, it’s better than the 62.5% Burberry reported during its last financial year. And it’s not far behind the 67% achieved by LVMH, owner of Louis Vuitton and Dior, in 2024.
This is a far cry from Dr Martens’ working-class roots. In 1960, shortly after the company was launched, its boots were sold to factory workers at £2 a pair. At todayâs prices, this would be equivalent to just under £59.Â
But the group has an ambition to become the worldâs âmost-desired premium footwear brandâ so itâs clearly no accident that itâs seeking to move to upmarket status.
Green shoots
Dr Martens most recent update describes trading in America as âpositiveâ. Asia’s also doing well. By contrast, the UK market is described as âchallengingâ.
Even so, the group confirmed it expects to deliver an adjusted PBT of around £56m for FY26. Yet despite its recent problems, it retains a global brand with an instantly-recognisable design. With an addressable market worth £179bn, the potential’s huge if it can get things right.
Personally, although I acknowledge that the business is going in the right direction, I canât see it recapturing its former glories. I think price rises are taking it away from its core market. Also, with much of its manufacturing base in the Far East, its US imports are vulnerable to President Trumpâs erratic trade policy.
I wish the group well but itâs not for me. Iâm not sure how it can embrace its reputation for ârebellious self-expressionâ with its desire to be viewed as a manufacturer of premium footwear.
The post It’s been a great week for this FTSE 250 legend. But will it last? appeared first on The Motley Fool UK.
Should you invest £1,000 in Rolls Royce right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.
And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Rolls Royce made the list?
More reading
- Could this FTSE 250 stock be like buying Rolls-Royce shares back in 2023?
- £10,000 in Dr Martens shares at IPO is now worthâ¦
- These UK stocks sit at 52-week highs. But I’m avoiding them!
James Beard has no position in any of the shares mentioned. The Motley Fool UK has recommended Burberry Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
